Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in ... Figure 1 Effect of Ang II treatment.

Published bySukarno Setiabudi Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in ... Figure 1 Effect of Ang II treatment."— Presentation transcript:

1 Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in ... Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in saline-infused and Ang II-infused mice by western blot analysis (t-test). (B) Immunofluorescence analysis of IL-12p35 protein expression in aortas in each group (×200). (C) Effect of Ang II treatment on IL-12p35 mRNA expression in Mø, B lymphocytes, T lymphocytes, and DCs (t-test). (D) Double immunofluorescence staining of anti-F4/80 and anti-IL-12p35 in Ang II-infused mice (×400). N = 6 in each group. *P < 0.05 vs. the saline group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 2 SBP and HR of angiotensin II-infused mice were measured using a tail-cuff. (A) SBP was detected at different ... Figure 2 SBP and HR of angiotensin II-infused mice were measured using a tail-cuff. (A) SBP was detected at different time points in each group (two-way ANOVA). (B) The HR was detected in the four groups. IL-12p35 KO = p35 KO. N = 8 in each group (two-way ANOVA). *P < 0.05 vs. the control group. <sup>#</sup>P < 0.05 vs. the Ang II-treated group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Figure 5 Effect of IL-12p35 KO on SMC differentiation
Figure 5 Effect of IL-12p35 KO on SMC differentiation. (A) Aortic OPN and SM22a protein expression was detected by ... Figure 5 Effect of IL-12p35 KO on SMC differentiation. (A) Aortic OPN and SM22a protein expression was detected by immunofluorescence staining (×200); n = 5 in each group. *P < 0.05 vs. the control group. <sup>#</sup>P < 0.05 vs. the Ang II-treated group. (B) iNOS mRNA levels in macrophages and OPN and SM22a mRNA levels in SMCs were measured by RT-qPCR (two-way ANOVA). N = 5 in each group. IL-12p35 KO = p35 KO. *P < 0.05 vs. the WT Mø+WT CD4+Ang II group. <sup>#</sup>P < 0.05 vs. the KO Mø+WT CD4+Ang II group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 4 Effect of IL-12p35 KO on M1 macrophage differentiation
Figure 4 Effect of IL-12p35 KO on M1 macrophage differentiation. (A) Double immunofluorescence staining of anti-F4/80 ... Figure 4 Effect of IL-12p35 KO on M1 macrophage differentiation. (A) Double immunofluorescence staining of anti-F4/80 and anti-CD80 in the four groups (×200). (B–G) The mRNA expression levels of iNOS, IL-1β, IL-6, IL-17, TNF-α, and IFN-γ in each group were measured by RT-qPCR (two-way ANOVA). (D) The p-STAT1, T-STAT1, p-P65, T-P65, and GAPDH levels were measured by western blotting (two-way ANOVA). (E) Double immunofluorescence staining of anti-F4/80 and anti-p-P65 in the Ang II group and the Ang II+IL-12p35 group (200×). IL-12p35 KO = p35 KO. N = 5–6 in each group. *P < 0.05 vs. the control group. <sup>#</sup>P < 0.05 vs. the Ang II-treated group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

5 Figure 6 Effect of rIL-12 on SBP and vascular dysfunction
Figure 6 Effect of rIL-12 on SBP and vascular dysfunction. (A) The SBP in each group was detected using a tail-cuff at ... Figure 6 Effect of rIL-12 on SBP and vascular dysfunction. (A) The SBP in each group was detected using a tail-cuff at different time points (one-way ANOVA). N = 8 in each group. (B, D) The effect of rIL-12 on ACh-or SNP-induced relaxation was measured in endothelial-intact aortas isolated from the four groups (one-way ANOVA). N = 5 in each group. (C) The effect of IL-22 on PE-induced contraction was measured in endothelial-intact aortas isolated from each group (one-way ANOVA). N = 5 in each group. (E) IL-12p40 and EBI3 protein expression levels were measured by immunofluorescence staining (×200); n = 8 in each group. (F) IL-12Rβ1 and gp130 mRNA levels in these groups were measured by RT-qPCR (one-way ANOVA); n = 8 in each group. *P < 0.05 vs. the Ang II+PBS group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

6 Figure 3 Effect of IL-12p35 KO on Ang II-induced vascular dysfunction
Figure 3 Effect of IL-12p35 KO on Ang II-induced vascular dysfunction. (A) The effect of IL-12p35 KO on ACh-induced ... Figure 3 Effect of IL-12p35 KO on Ang II-induced vascular dysfunction. (A) The effect of IL-12p35 KO on ACh-induced relaxation was measured in endothelial-intact aortas isolated from the four groups (two-way ANOVA). (B) The effect of IL-12p35 KO on PE-induced contraction was measured in endothelial-intact aortas isolated from each group (two-way ANOVA). (C) The effect of IL-12p35 KO on SNP-induced relaxation was measured in endothelial-intact aortas isolated from each group (two-way ANOVA). (D) Effect of indomethacin on ACh-induced relaxation (two-way ANOVA). IL-12p35 KO=p35 KO. N = 6 in each group. *P < 0.05 vs. the control group. <sup>#</sup>P < 0.05 vs. the Ang II-treated group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

7 Figure 7 Plasma IL-12 levels in hypertensive patients
Figure 7 Plasma IL-12 levels in hypertensive patients. (A) Plasma IL-12 levels in control subjects and hypertensive ... Figure 7 Plasma IL-12 levels in hypertensive patients. (A) Plasma IL-12 levels in control subjects and hypertensive patients were detected by ELISA (Mann–Whitney U test). (B, C) Correlation analysis of SBP, DBP, and IL-12 levels in hypertensive patients (Spearman's correlation analysis). ****P <  vs. the control group. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Cardiovasc Res, Volume 115, Issue 6, 30 November 2018, Pages 1102–1113, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 1 Effect of Ang II treatment for 4 weeks on aortic IL-12p35 expression. (A) IL-12p35 levels were measured in ... Figure 1 Effect of Ang II treatment."

Similar presentations

(A) Western ... (A) Western blot showing DTX1 knockdown with siRNA in human CD4+ T cells. Actin was used as the loading control. (B) Purified.

(A) Western ... (A) Western blot showing DTX1 knockdown with siRNA in human CD4+ T cells. Actin was used as the loading control. (B) Purified.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Multivariable-adjusted predictors of PAC

Figure 1 Multivariable-adjusted predictors of PAC
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
bDMARD: biologic DMARD.

bDMARD: biologic DMARD.

Similar presentations

Ads by Google